Interpace Diagnostics (IDXG) Reports Q1 EPS of $0.42

Interpace Diagnostics (NASDAQ: IDXG) reported Q1 EPS of $0.42, versus ($2.26) reported last year. Revenue for the quarter came in at $3.5 million, versus $3.04 million reported last year.

For earnings history and earnings-related data on Interpace Diagnostics (IDXG) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Terra Innovatum Global N.V. (NKLR) Misses Q2 EPS by 12c
• Baidu slips as Q2 results miss estimates despite growth in AI cloud business